Все публикации

0:03:44

Comparing Outcomes in Younger Multiple Myeloma Patients | Marc Braunstein, MD, PhD | #ASH24

0:06:34

High-Fiber NUTRIVENTION Study for Delaying Progression of Myeloma | Urvi Shah, MD | #ASH24

0:18:37

Bispecific Antibodies in Multiple Myeloma | Dallas Roundtable November 2, 2024

1:15:58

Nutrition and the Gut Microbiome: Exploring Their Role in Multiple Myeloma

0:57:03

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

0:37:58

RoundTable Audience Q&A with Faculty | New York Roundtable October 19, 2024

0:33:16

The Future of Myeloma Care | New York Roundtable October 19, 2024

0:59:41

Caring for the Caregiver: Effective Stress Management Strategies

0:42:06

Newly Diagnosed Multiple Myeloma | Detroit Roundtable October 12, 2024

0:35:01

The Evolving World of Immunotherapies | Detroit Roundtable October 12, 2024

0:37:02

All Myeloma Therapies for All Patients | Detroit Roundtable October 12, 2024

0:26:14

Multiple Myeloma: Past, Present, and Personalized | Detroit Roundtable, October 12, 2024

0:46:10

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients

0:03:06

Results of a Phase 1 Clinical Trial of Belantamab Mafadotin in RRMM | Shebli Atrash, MD | IMS 2024

0:02:44

Talquetamab Use in Treating Relapsed Refractory Multiple Myeloma | Shebli Atrash, MD | IMS 2024

0:01:22

Talquetamab as a Bridging Therapy to CAR-T Treatment | Shebli Atrash, MD | IMS 2024

0:04:00

OS with Cilta-cel vs SOC in Lenalidomide Refractory MM | María-Victoria Mateos, MD, PhD | IMS 2024

0:03:37

Strategies used to Prevent T-cell Exhaustion in Myeloma | Hermann Einsele, MD, FRCP | IMS 2024

0:04:52

The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024

0:02:30

Defining High Risk Multiple Myeloma | Wee Joo Chng, MD, PhD | IMS 2024

0:02:50

Positioning Model to Evaluate CARVYKTI in Second Line vs Later Lines | Rafael Fonseca, MD | IMS 2024

0:03:34

Predictors of delayed responses to teclistamab in myeloma | Rahul Banerjee, MD | IMS 2024

0:03:45

MILESTONE Trial: MRD Adapted Deferral of Transplant in Dysproteinemia | Susan Bal, MD | IMS 2024

0:03:02

Newer Therapies for RRMM: Impact on Aging Patients | Suzanne Lentzsch, MD, PhD | IMS 2024